SCHEMBL5037863

SCHEMBL5037863

COc1cc(F)c(C(OC)C(=O)O)c(F)c1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 4/20 0.42
APP P05067 1/20 0.39
CYP2C19 P33261 1/20 0.39
TAAR1 Q96RJ0 1/20 0.38
CPS1 P31327 1/20 0.37
AKR1C3 P42330 4/20 0.37
AKR1C2 P52895 4/20 0.37
ALDH1A1 P00352 2/20 0.36
GAA P10253 1/20 0.36
FFAR1 O14842 1/20 0.36
FFAR4 Q5NUL3 1/20 0.36
LDHA P00338 1/20 0.36
PTGS1 P23219 2/20 0.36
CDC42 P60953 1/20 0.36
RAC1 P63000 1/20 0.36
CYP1A2 P05177 1/20 0.36
TSHR P16473 1/20 0.36
SLC22A6 Q4U2R8 1/20 0.36
HDAC1 Q13547 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5038048 0.83 PTGS2 (0.39) PTGS2APPCYP2C19TAAR1AKR1C3
SCHEMBL2345247 0.83 PTGS2 (0.45) PTGS2CPS1AKR1C3AKR1C2ALDH1A1
SCHEMBL1462346 0.81 PTGS2 (0.44) PTGS2APPCYP2C19TAAR1CPS1
SCHEMBL17284101 0.80 PTGS2 (0.54) PTGS2APPCYP2C19TAAR1AKR1C3
SCHEMBL2347876 0.78 PTGS2 (0.45) PTGS2APPCYP2C19CPS1AKR1C3
SCHEMBL2352769 0.78 ALDH1A1 (0.49) AKR1C3AKR1C2ALDH1A1GAA
SCHEMBL18890127 0.76 ALDH1A1 (0.44) PTGS2AKR1C3AKR1C2ALDH1A1LDHA
SCHEMBL22609776 0.75 PTGS2 (0.40) PTGS2APPCYP2C19TAAR1CPS1
SCHEMBL2349189 0.75 AKR1C3 (0.43) PTGS2APPCYP2C19CPS1AKR1C3
SCHEMBL5041275 0.74 LDHA (0.40) PTGS2APPCYP2C19AKR1C3AKR1C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567498-B1 MANDELIC ACID DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-01-23 EP disclosed
US-7129238-B2 Mandelic acid derivatives HOFFMANN-LA ROCHE INC. (US) 2006-10-31 US disclosed
EP-1567498-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2005-08-31 EP disclosed
US-20040122057-A1 Novel mandelic acid derivatives HOFFMANN-LA ROCHE INC. 2004-06-24 US disclosed
WO-2004048335-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2004-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122057-A1 Novel mandelic acid derivatives F7, F11, F9 PTGS2 3734/4885APP 4301/4885CYP2C19 585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.